Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Myasthenia Gravis × Abatacept × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1 Multiple Myeloma 1

Interventions

thymoglobulin 1 satralizumab 1 rhoA GTP-Binding Protein 1 eculizumab 1 Sugars 1 Steroids 1 Prednisone 1 Methylprednisolone 1 Mesna 1 Immunoglobulins 1 Hizentra 1 Hematopoietic Stem Cell Transplantation 1 Granulocyte Colony-Stimulating Factor 1 Cyclophosphamide 1 CK-2017357 1 Bortezomib 1 Amifampridine 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03059888 2019-11-22

Trial of Orencia in Patients With Myasthenia Gravis

Johns Hopkins University

Phase EARLY_PHASE1 Terminated

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡